These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10084037)

  • 1. Tuberculosis prophylaxis in patients with steroid treatment and systemic rheumatic diseases. A case-control study.
    Hernández-Cruz B; Ponce-de-León-Rosales S; Sifuentes-Osornio J; Ponce-de-León-Garduño A; Díaz-Jouanen E
    Clin Exp Rheumatol; 1999; 17(1):81-7. PubMed ID: 10084037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium tuberculosis infection in patients with systemic rheumatic diseases. A case-series.
    Hernández-Cruz B; Sifuentes-Osornio J; Ponce-de-León Rosales S; Ponce-de-León Garduño A; Díaz-Jouanen E
    Clin Exp Rheumatol; 1999; 17(3):289-96. PubMed ID: 10410261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.
    Mok MY; Lo Y; Chan TM; Wong WS; Lau CS
    J Rheumatol; 2005 Apr; 32(4):609-15. PubMed ID: 15801014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence.
    Falagas ME; Voidonikola PT; Angelousi AG
    Int J Antimicrob Agents; 2007 Dec; 30(6):477-86. PubMed ID: 17913470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids.
    Park JW; Curtis JR; Lee H; Lee JK; Song YW; Lee EB
    PLoS One; 2020; 15(12):e0244239. PubMed ID: 33382731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is a purified protein derivative skin test and subsequent antituberculous chemoprophylaxis really necessary in systemic rheumatic disease patients receiving corticosteroids?
    Andonopoulos AP; Safridi C; Karokis D; Bounas A
    Clin Rheumatol; 1998; 17(3):181-5. PubMed ID: 9694048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of transaminase elevation during concomitant methotrexate and isoniazid therapy.
    Ekochin LH; Manadan AM; Aggarwal R; Sequeira W; Block JA
    J Rheumatol; 2009 Sep; 36(9):2127. PubMed ID: 19738229
    [No Abstract]   [Full Text] [Related]  

  • 8. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
    Moreno S; Miralles P; Diaz MD; Baraia J; Padilla B; Berenguer J; Alberdi JC
    Arch Intern Med; 1997 Aug 11-25; 157(15):1729-34. PubMed ID: 9250234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of isoniazid prophylaxis for prevention of tuberculosis in haemopoietic stem cell transplant recipients.
    Ahmed P; Anwar M; Khan B; Altaf C; Ullah K; Raza S; Hussain I
    J Pak Med Assoc; 2005 Sep; 55(9):378-81. PubMed ID: 16302471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNFalpha.
    Hanta I; Ozbek S; Kuleci S; Sert M; Kocabas A
    Clin Rheumatol; 2007 Nov; 26(11):1867-70. PubMed ID: 17332973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of prophylaxis against tuberculosis in patients infected with HIV].
    Arbeláez MP; Arbeláez A; Gómez RD; Rojas C; Vélez L; Arias SL; Nagles J; Peláez LM; Betancourt G; Velásquez G
    Biomedica; 2007 Dec; 27(4):515-25. PubMed ID: 18320119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy.
    Vikrant S; Agarwal SK; Gupta S; Bhowmik D; Tiwari SC; Dash SC; Guleria S; Mehta SN
    Transpl Infect Dis; 2005; 7(3-4):99-108. PubMed ID: 16390397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
    Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long term steroid treatment.
    Gaitonde S; Pathan E; Sule A; Mittal G; Joshi VR
    Ann Rheum Dis; 2002 Mar; 61(3):251-3. PubMed ID: 11830432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.
    Zar HJ; Cotton MF; Strauss S; Karpakis J; Hussey G; Schaaf HS; Rabie H; Lombard CJ
    BMJ; 2007 Jan; 334(7585):136. PubMed ID: 17085459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to tuberculosis among newborns in a nursery: decision analysis for initiation of prophylaxis.
    Berkowitz FE; Severens JL; Blumberg HM
    Infect Control Hosp Epidemiol; 2006 Jun; 27(6):604-11. PubMed ID: 16755481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial.
    Samandari T; Agizew TB; Nyirenda S; Tedla Z; Sibanda T; Shang N; Mosimaneotsile B; Motsamai OI; Bozeman L; Davis MK; Talbot EA; Moeti TL; Moffat HJ; Kilmarx PH; Castro KG; Wells CD
    Lancet; 2011 May; 377(9777):1588-98. PubMed ID: 21492926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay.
    Matulis G; Jüni P; Villiger PM; Gadola SD
    Ann Rheum Dis; 2008 Jan; 67(1):84-90. PubMed ID: 17644549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population.
    Kim HA; Yoo CD; Baek HJ; Lee EB; Ahn C; Han JS; Kim S; Lee JS; Choe KW; Song YW
    Clin Exp Rheumatol; 1998; 16(1):9-13. PubMed ID: 9543555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.
    Halsey NA; Coberly JS; Desormeaux J; Losikoff P; Atkinson J; Moulton LH; Contave M; Johnson M; Davis H; Geiter L; Johnson E; Huebner R; Boulos R; Chaisson RE
    Lancet; 1998 Mar; 351(9105):786-92. PubMed ID: 9519950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.